Anifrolumab in ARF1-related disorder: A case report of clinical response and review of its use in type I interferonopathies. // Clinical Immunology Communications. – URL: https://www.sciencedirect.com/science/article/pii/S277261342600017X?dgcid=rss_sd_all
Anifrolumab in ARF1-related disorder: A case report of clinical response and review of its use in type I interferonopathies. Clinical Immunology Communications. https://www.sciencedirect.com/science/article/pii/S277261342600017X?dgcid=rss_sd_all
“Anifrolumab in ARF1-related disorder: A case report of clinical response and review of its use in type I interferonopathies.” Clinical Immunology Communications.
@article{article288,
title = {Anifrolumab in ARF1-related disorder: A case report of clinical response and review of its use in type I interferonopathies},
journal = {Clinical Immunology Communications},
url = {https://www.sciencedirect.com/science/article/pii/S277261342600017X?dgcid=rss_sd_all}
}